OPPENHEIMER & CO INC - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 27 filers reported holding ACASTI PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q4 2020$73,000
+87.2%
224,965
+15.5%
0.00%
+100.0%
Q3 2020$39,000
-58.1%
194,786
-1.8%
0.00%
-50.0%
Q2 2020$93,000
+24.0%
198,3890.0%0.00%0.0%
Q1 2020$75,000
-58.8%
198,389
+166.4%
0.00%
-60.0%
Q4 2019$182,000
+75.0%
74,457
+35.0%
0.01%
+66.7%
Q3 2019$104,00055,1590.00%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders